Auricle
PrivateCompany Overview
Auricle is a medical device company that manufactures a medical instrument for tinnitus treatment. The company's device uses bimodal neuromodulation, combining auditory frequencies and timed somatosensory stimuli to suppress tinnitus-generating neurons.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
tinnitus treatmentbimodal neuromodulationsomatic tinnitusneuromodulation devicewearable medical devicenon-invasive treatmentaudiologysound therapyelectrical stimulationFDA clearanceclinical developmentuniversity spin-out
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Auricle Comparables
Compare Auricle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neuromod Devices | 86% | |
| Oto | 55% | |
| Mobia Medical | 45% | |
Auricle Funding Rounds
Historical fundraising activity
Auricle Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Auricle's valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Francisco, California
Year Founded2019
Last Funding—